The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression. (Q40248309)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2006
edit
Language Label Description Also known as
English
The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression.
scientific article published on July 2006

    Statements

    The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit